| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | 2 | 2 | 2 | 1 | 2 | 1 | 3 | 5 | 3 | 3 | 3 | 3 |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 0.52 |
—
—
—
|
| 2025 | 0.48 |
—
—
—
—
|
| 2024 | 0.48 |
—
—
—
—
|
| 2023 | 0.44 |
—
—
—
—
|
| 2022 | 0.44 |
—
—
—
—
|
| 2021 | 0.40 |
—
—
—
—
|
| 2020 | 0.40 |
—
—
—
—
|
| 2019 | 0.36 |
—
—
—
—
|
| 2018 | 0.36 |
—
—
—
—
|
| 2017 | 0.28 |
—
—
—
—
|
| 2016 | 0.24 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 819.73 | 599.67 | 322.00 | 354.83 |
| Receivables | 422.12 | 471.43 | 786.91 | 1,109.71 |
| Inventory | 309.97 | 298.49 | 379.55 | 403.30 |
| Other | 61.24 | 17.73 | 33.27 | 30.01 |
| 2,162.04 | 1,816.40 | 1,949.30 | 2,366.02 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 180.13 | 134.79 | 269.19 | 383.42 |
| ST’ Debt | — | — | 200.00 | — |
| Other | 7.38 | — | — | — |
| 659.95 | 624.58 | 1,115.21 | 1,113.52 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1,282.49 | 1,328.99 | — | — |
—
|
| ’25 | 685.68 | 651.80 | 769.21 | 1,083.34 |
3,190.02
|
| ’24 | 599.82 | 729.88 | 737.30 | 752.88 |
2,819.88
|
| ’23 | 617.53 | 684.44 | 703.73 | 670.60 |
2,676.30
|
| ’22 | 755.37 | 840.77 | 827.07 | 731.84 |
3,155.05
|
| ’21 | 781.61 | 1,085.73 | 950.50 | 885.05 |
3,702.88
|
| ’20 | 704.36 | 838.66 | 819.48 | 758.97 |
3,121.47
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 265.12 | 469.14 | — | — |
—
|
| ’25 | 161.64 | 182.09 | 49.05 | 281.64 |
674.42
|
| ’24 | 7.28 | 216.07 | 166.27 | 282.56 |
672.18
|
| ’23 | 19.34 | 142.77 | 174.35 | 248.78 |
585.23
|
| ’22 | 7.46 | 115.46 | 271.60 | 183.40 |
577.92
|
| ’21 | 38.14 | 206.28 | 522.66 | 331.28 |
1,098.37
|
| ’20 | 43.10 | 222.90 | 342.51 | 260.42 |
868.94
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 200.39 | 378.43 | — | — |
—
|
| ’25 | 97.62 | 131.68 | 2.36 | 218.75 |
450.41
|
| ’24 | (36.74) | 171.22 | 114.43 | 225.17 |
474.08
|
| ’23 | (22.11) | 103.51 | 139.74 | 204.44 |
425.59
|
| ’22 | (36.54) | 69.71 | 232.68 | 152.24 |
418.08
|
| ’21 | (1.11) | 171.58 | 493.46 | 301.97 |
965.89
|
| ’20 | 6.40 | 175.58 | 279.65 | 222.32 |
683.96
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 2.53 | 2.38 | — | — |
—
|
| ’25 | 0.61 | 0.49 | 0.75 | 1.63 |
3.47
|
| ’24 | 0.40 | 1.14 | 0.89 | 0.90 |
3.32
|
| ’23 | 0.50 | 0.73 | 0.78 | 0.72 |
2.73
|
| ’22 | 0.92 | 1.16 | 1.10 | 1.04 |
4.22
|
| ’21 | 1.09 | 1.76 | 1.41 | 1.29 |
5.56
|
| ’20 | 0.97 | 1.05 | 1.21 | 1.05 |
4.28
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 67.81 | 81.08 | 92.29 | 65.77 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 167.69 | 119.20 | 163.21 | 205.00 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,500 | 6,500 | 6,500 | 6,600 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.49 | 0.41 | 0.43 | 0.48 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,155.05 | 2,676.30 | 2,819.88 | 3,190.02 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 59.18% | 57.42% | 58.48% | 58.22% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 840.39 | 525.57 | 609.09 | 653.26 | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 26.64% | 19.64% | 21.60% | 20.48% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 715.50 | 448.75 | 542.37 | 554.05 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 110.68 | 110.89 | 119.74 | 127.98 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.91 | 17.34 | 17.73 | 20.05 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 4.52 | 2.91 | 3.41 | 3.48 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.65 | 3.79 | 4.23 | 4.24 | ‡‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.01) | (1.03) | (1.25) | (1.41) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.64 | 2.76 | 2.98 | 2.83 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.47 | 16.37 | 17.72 | 17.57 | ‡‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 158.43 | 154.31 | 159.08 | 159.12 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.01 | 35.88 | 37.14 | 55.46 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.32 | 6.04 | 7.10 | 9.65 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.55 | 6.40 | 7.11 | 11.02 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.07 | 5.77 | 6.92 | 9.64 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 30.70 | 36.28 | 41.18 | 68.26 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 577.92 | 585.23 | 672.18 | 674.42 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (159.84) | (159.64) | (198.09) | (224.01) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 418.08 | 425.59 | 474.08 | 450.41 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,511.65 | 1,502.08 | 1,191.82 | 834.09 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 114.12 | — | — | 200.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (780.27) | (819.72) | (599.67) | (122.00) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,451.29 | 2,525.90 | 2,819.29 | 2,795.75 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.57% | 12.84% | 15.08% | 14.04% | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 31.12% | 18.35% | 16.72% | 15.20% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.54% | 18.03% | 20.29% | 19.73% | ‡‡‡‡‡ | — | — |
ROE
|
Teradyne (TER), a powerhouse in semiconductor test equipment and robotics, has mastered the semiconductor cycle’s wild swings—from 2016 losses post-acquisition to explosive 2020-2021 peaks amid chip shortages, a 2022-2023 trough, and now an AI-fueled rebound. Revenue rocketed from $1.75B in 2016 to $3.7B in 2021 before dipping to $2.68B in 2023, rebounding 5% to $2.82B in 2024, with EPS surging from -$0.21 to a $6.19 high and back to $3.41. Strong correlations (r≈0.85-0.92) between revenue/EPS growth and stock prices highlight how semi-test exposure amplifies booms, while steady 57-59% gross margins and ~6,500 employees signal pricing power and efficiency.
A cash-rich balance sheet (net cash ~$1B), disciplined buybacks shrinking shares 21%, and ROE above industry norms fortify TER against volatility, with FCF recovering to $474M in 2024. Projections dazzle: revenue +13% to $3.19B in 2025 and +31% to $4.19B in 2026, EPS leaping 73% to $5.91 then $7.93, powered by AI testing for NVIDIA/TSMC chips and robotics growth. Premium multiples (PE 37x, EV/Sales 6.9x) echo historical setups yielding +45% returns.
Routine insider sells amid high valuations temper enthusiasm slightly, but AI tailwinds outweigh cyclical risks like CAPEX cuts or trade tensions. Data models show 65-78% odds of hitting targets, with 2021-like upside potentially driving 40%+ gains—making TER a compelling cyclical play for patient investors.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.